Trump Administration Proposes New Regulations to Clean Up Health Care Pricing Disclosures and Spreadsheets

Stat News Health•Published: Oct 6, 2026 12:03 AM IST

The Trump administration has released new regulations aimed at bringing greater transparency to health care costs by forcing insurance companies to publish streamlined spreadsheets of prices paid to providers. Mehmet Oz, the head of Medicare and Medicaid, announced that the government will also begin developing a prescription drug price disclosure system next month, with a final plan targeted for May. Enforcement of these comprehensive transparency requirements is scheduled to take full effect by the end of 2027.

Streamlined Spreadsheets: Insurance companies will be forced to publish cleaned-up pricing files while stripping out meaningless data that previously clogged spreadsheets.
Prescription Drug Timeline: Officials announced the system for disclosing prescription drug prices will start development next month with a hopeful final plan by next May.
Enforcement Deadline: The federal government has established a firm timeline to fully enforce these new price disclosure requirements by the end of 2027.

The Context & Background

This push builds upon previous transparency initiatives, following last year's decision by the Trump administration to delay finalizing drug price disclosure rules after heavy pushback from drug companies and pharmacy benefit managers.

Why it matters:These transparency regulations empower patients and employers by exposing hidden costs within the health care system, potentially driving down prices through increased market competition. However, overcoming intense resistance from powerful pharmaceutical companies and pharmacy benefit managers will be critical to achieving meaningful financial reform.

Enjoyed this 2-minute breakdown?

Share it with your colleagues and friends!